Global Fenofibric Acid Market

Fenofibric Acid Comprehensive Study by Type (45 mg Delayed Release Capsules, 135 mg Delayed Release Capsules), Application (Hospital, Drug store) Players and Region - Global Market Outlook to 2030

Fenofibric Acid Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled

Report Objectives / Segmentation Covered

By Type
  • 45 mg Delayed Release Capsules
  • 135 mg Delayed Release Capsules
By Application
  • Hospital
  • Drug store
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Its Role as a Marine Xenobiotic Metabolite and a Drug Metabolite
      • 3.2.2. Use as a Proper Diet to Treat High Cholesterol and Triglyceride
    • 3.3. Market Challenges
      • 3.3.1. Need for Precautionary Measures Before Using Fenofibric Acid
      • 3.3.2. Side Effects Associated with Its Use
    • 3.4. Market Trends
      • 3.4.1. Technical Advancement in Fenofibric Acid
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fenofibric Acid, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Fenofibric Acid (Value)
      • 5.2.1. Global Fenofibric Acid by: Type (Value)
        • 5.2.1.1. 45 mg Delayed Release Capsules
        • 5.2.1.2. 135 mg Delayed Release Capsules
      • 5.2.2. Global Fenofibric Acid by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Drug store
      • 5.2.3. Global Fenofibric Acid Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Fenofibric Acid: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AbbVie (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Lupin (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Impax Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mylan (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
  • 7. Global Fenofibric Acid Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Fenofibric Acid (Value)
      • 7.2.1. Global Fenofibric Acid by: Type (Value)
        • 7.2.1.1. 45 mg Delayed Release Capsules
        • 7.2.1.2. 135 mg Delayed Release Capsules
      • 7.2.2. Global Fenofibric Acid by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Drug store
      • 7.2.3. Global Fenofibric Acid Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fenofibric Acid: by Type(USD Million)
  • Table 2. Fenofibric Acid 45 mg Delayed Release Capsules , by Region USD Million (2018-2023)
  • Table 3. Fenofibric Acid 135 mg Delayed Release Capsules , by Region USD Million (2018-2023)
  • Table 4. Fenofibric Acid: by Application(USD Million)
  • Table 5. Fenofibric Acid Hospital , by Region USD Million (2018-2023)
  • Table 6. Fenofibric Acid Drug store , by Region USD Million (2018-2023)
  • Table 7. South America Fenofibric Acid, by Country USD Million (2018-2023)
  • Table 8. South America Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 9. South America Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 10. Brazil Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 11. Brazil Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 12. Argentina Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 13. Argentina Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 14. Rest of South America Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 15. Rest of South America Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 16. Asia Pacific Fenofibric Acid, by Country USD Million (2018-2023)
  • Table 17. Asia Pacific Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 18. Asia Pacific Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 19. China Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 20. China Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 21. Japan Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 22. Japan Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 23. India Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 24. India Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 25. South Korea Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 26. South Korea Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 27. Taiwan Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 28. Taiwan Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 29. Australia Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 30. Australia Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 31. Rest of Asia-Pacific Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 32. Rest of Asia-Pacific Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 33. Europe Fenofibric Acid, by Country USD Million (2018-2023)
  • Table 34. Europe Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 35. Europe Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 36. Germany Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 37. Germany Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 38. France Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 39. France Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 40. Italy Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 41. Italy Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 42. United Kingdom Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 43. United Kingdom Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 44. Netherlands Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 45. Netherlands Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 46. Rest of Europe Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 47. Rest of Europe Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 48. MEA Fenofibric Acid, by Country USD Million (2018-2023)
  • Table 49. MEA Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 50. MEA Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 51. Middle East Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 52. Middle East Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 53. Africa Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 54. Africa Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 55. North America Fenofibric Acid, by Country USD Million (2018-2023)
  • Table 56. North America Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 57. North America Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 58. United States Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 59. United States Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 60. Canada Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 61. Canada Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 62. Mexico Fenofibric Acid, by Type USD Million (2018-2023)
  • Table 63. Mexico Fenofibric Acid, by Application USD Million (2018-2023)
  • Table 64. Company Basic Information, Sales Area and Its Competitors
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Fenofibric Acid: by Type(USD Million)
  • Table 69. Fenofibric Acid 45 mg Delayed Release Capsules , by Region USD Million (2025-2030)
  • Table 70. Fenofibric Acid 135 mg Delayed Release Capsules , by Region USD Million (2025-2030)
  • Table 71. Fenofibric Acid: by Application(USD Million)
  • Table 72. Fenofibric Acid Hospital , by Region USD Million (2025-2030)
  • Table 73. Fenofibric Acid Drug store , by Region USD Million (2025-2030)
  • Table 74. South America Fenofibric Acid, by Country USD Million (2025-2030)
  • Table 75. South America Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 76. South America Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 77. Brazil Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 78. Brazil Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 79. Argentina Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 80. Argentina Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 81. Rest of South America Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 82. Rest of South America Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 83. Asia Pacific Fenofibric Acid, by Country USD Million (2025-2030)
  • Table 84. Asia Pacific Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 85. Asia Pacific Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 86. China Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 87. China Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 88. Japan Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 89. Japan Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 90. India Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 91. India Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 92. South Korea Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 93. South Korea Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 94. Taiwan Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 95. Taiwan Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 96. Australia Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 97. Australia Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 98. Rest of Asia-Pacific Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 99. Rest of Asia-Pacific Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 100. Europe Fenofibric Acid, by Country USD Million (2025-2030)
  • Table 101. Europe Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 102. Europe Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 103. Germany Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 104. Germany Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 105. France Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 106. France Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 107. Italy Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 108. Italy Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 109. United Kingdom Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 110. United Kingdom Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 111. Netherlands Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 112. Netherlands Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 113. Rest of Europe Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 114. Rest of Europe Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 115. MEA Fenofibric Acid, by Country USD Million (2025-2030)
  • Table 116. MEA Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 117. MEA Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 118. Middle East Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 119. Middle East Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 120. Africa Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 121. Africa Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 122. North America Fenofibric Acid, by Country USD Million (2025-2030)
  • Table 123. North America Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 124. North America Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 125. United States Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 126. United States Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 127. Canada Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 128. Canada Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 129. Mexico Fenofibric Acid, by Type USD Million (2025-2030)
  • Table 130. Mexico Fenofibric Acid, by Application USD Million (2025-2030)
  • Table 131. Research Programs/Design for This Report
  • Table 132. Key Data Information from Secondary Sources
  • Table 133. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fenofibric Acid: by Type USD Million (2018-2023)
  • Figure 5. Global Fenofibric Acid: by Application USD Million (2018-2023)
  • Figure 6. South America Fenofibric Acid Share (%), by Country
  • Figure 7. Asia Pacific Fenofibric Acid Share (%), by Country
  • Figure 8. Europe Fenofibric Acid Share (%), by Country
  • Figure 9. MEA Fenofibric Acid Share (%), by Country
  • Figure 10. North America Fenofibric Acid Share (%), by Country
  • Figure 11. Global Fenofibric Acid share by Players 2023 (%)
  • Figure 12. BCG Matrix for key Companies
  • Figure 13. AbbVie (United States) Revenue, Net Income and Gross profit
  • Figure 14. AbbVie (United States) Revenue: by Geography 2023
  • Figure 15. Lupin (India) Revenue, Net Income and Gross profit
  • Figure 16. Lupin (India) Revenue: by Geography 2023
  • Figure 17. Impax Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Impax Laboratories (United States) Revenue: by Geography 2023
  • Figure 19. Mylan (United States) Revenue, Net Income and Gross profit
  • Figure 20. Mylan (United States) Revenue: by Geography 2023
  • Figure 21. Global Fenofibric Acid: by Type USD Million (2025-2030)
  • Figure 22. Global Fenofibric Acid: by Application USD Million (2025-2030)
  • Figure 23. South America Fenofibric Acid Share (%), by Country
  • Figure 24. Asia Pacific Fenofibric Acid Share (%), by Country
  • Figure 25. Europe Fenofibric Acid Share (%), by Country
  • Figure 26. MEA Fenofibric Acid Share (%), by Country
  • Figure 27. North America Fenofibric Acid Share (%), by Country
List of companies from research coverage that are profiled in the study
  • AbbVie (United States)
  • Lupin (India)
  • Impax Laboratories (United States)
  • Mylan (United States)
Additional players considered in the study are as follows:
Alembic Pharmaceuticals (India) , Par Pharmaceutical (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 235 Pages 57 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Fenofibric Acid Market Quantitative research analysis
Global Fenofibric Acid Market Qualitative Industry Analysis
Global Fenofibric Acid Market Quantitative research analysis
Global Fenofibric Acid Market Qualitative Industry Analysis
Global Fenofibric Acid Market Quantitative research analysis
Global Fenofibric Acid Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Fenofibric Acid Market Report?

Have a Query? Click Here

Other Related Reports

Thyroid Function Tests Comprehensive Study by Type (TSH Tests (Thyroid Stimulating Hormone Test), FT4 Tests (Free T4), FT3 Tests (Free T3)), End User (Hospitals, Diagnostic Laboratories, Research Lab...
$ 3350
Cancer Profiling Comprehensive Study by Type (Breast Cancer, Lung Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Others (Melanoma, Colorectal, Bladder, Leukemia)), Application (Clinical, Scr...
$ 3750
Multipurpose Systems Comprehensive Study by Application (Ambulance, RHC, Home care, Intensive care room), Components (Hardware, Software), Modules (Biosignal acquisition module, Digital camera, Proce...
$ 3450
Fertility Services Comprehensive Study by Application (Fertility clinics, Hospitals, Surgical centers, Clinical Research Institutes), Treatment (Assistive reproductive technology (ART) (Artificial in...
$ 3750
Healthcare Interoperability Solutions Comprehensive Study by Type (Software Solutions {EMR/EHR, Lab Systems, Imaging Systems, Healthcare Information Exchange, Enterprise, Other(Medical Billing, Pract...
$ 3750
Molecular Diagnostics Comprehensive Study by Type (Instruments, Reagents, Software & Services), Application (Infectious Diseases (HIV, HPV, Tuberculosis and Other Infectious Diseases), Oncology (Brea...
$ 3750
Thyroid Function Tests Comprehensive Study by Type (TSH Tests (Thyroid Stimulating Hormone Test), FT4 Tests (Free T4), FT3 Tests (Free T3)), End User (Hospitals, Diagnostic Laboratories, Research Lab...
$ 3350
Cancer Profiling Comprehensive Study by Type (Breast Cancer, Lung Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Others (Melanoma, Colorectal, Bladder, Leukemia)), Application (Clinical, Scr...
$ 3750
Multipurpose Systems Comprehensive Study by Application (Ambulance, RHC, Home care, Intensive care room), Components (Hardware, Software), Modules (Biosignal acquisition module, Digital camera, Proce...
$ 3450
Fertility Services Comprehensive Study by Application (Fertility clinics, Hospitals, Surgical centers, Clinical Research Institutes), Treatment (Assistive reproductive technology (ART) (Artificial in...
$ 3750
Healthcare Interoperability Solutions Comprehensive Study by Type (Software Solutions {EMR/EHR, Lab Systems, Imaging Systems, Healthcare Information Exchange, Enterprise, Other(Medical Billing, Pract...
$ 3750
Molecular Diagnostics Comprehensive Study by Type (Instruments, Reagents, Software & Services), Application (Infectious Diseases (HIV, HPV, Tuberculosis and Other Infectious Diseases), Oncology (Brea...
$ 3750
Thyroid Function Tests Comprehensive Study by Type (TSH Tests (Thyroid Stimulating Hormone Test), FT4 Tests (Free T4), FT3 Tests (Free T3)), End User (Hospitals, Diagnostic Laboratories, Research Lab...
$ 3350
Cancer Profiling Comprehensive Study by Type (Breast Cancer, Lung Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Others (Melanoma, Colorectal, Bladder, Leukemia)), Application (Clinical, Scr...
$ 3750
Multipurpose Systems Comprehensive Study by Application (Ambulance, RHC, Home care, Intensive care room), Components (Hardware, Software), Modules (Biosignal acquisition module, Digital camera, Proce...
$ 3450
Fertility Services Comprehensive Study by Application (Fertility clinics, Hospitals, Surgical centers, Clinical Research Institutes), Treatment (Assistive reproductive technology (ART) (Artificial in...
$ 3750